Manufacturing consultancy up 150% as life sciences prepare for a digital future
Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.
Zenith Technologies has seen a 150% rise in demand for its consultancy arm services. The company's consultancy has seen an increasing appetite for digitised manufacturing and using data to improve GMP manufacturing over the past 12 months.
The growth of the service in 2018 was driven by a need to aid customers in collecting, contextualising and finding insights in their stored data. These insights can then be used to make informed decisions on production processes and the supply chain.
Jaqueline Hora, Global Digital and Data Analytics Lead at Zenith Technologies said: “The life science industry has seen a remarkable trend towards innovation utilising data and technology effectively. Digital strategies, as well as manufacturing execution systems (MES) and automation, are in great demand as a result.
“For customers implementing these digital strategies, project decision support as well as process, technology and project execution knowledge, are essential to ensure success.
“Our Consultancy team supports customers that are considering new technology projects and assists in developing strategies, governance and standards to provide a framework for success.
“Whether it be justifying ROI, validating a customer’s strategy, process and methodology implementation expertise or help with technology selection, Zenith has been there to support its customer base.
“Zenith’s intimate understanding of manufacturing systems, extensive process knowledge and significant experience serving the life science sector has ensured that our customers have the insight needed to make the best decision.”
The increase is in part a direct result of the emergence of Industry 4.0 with data integrity, data analytics, the internet of things, and cloud strategies becoming a reality throughout the life science industry.
The team’s growth is projected to continue into 2019 as the life science industry increases its focus on digitisation and using data to improve GMP manufacturing practices.
In a recent survey of the industry, Zenith found nearly 60% of participants believe that Industry 4.0 will drive the most change in life science over the next 5 years, with 75% of those aiming to invest in people to take advantage of emerging technologies.
News 3 ways ChatGPT will impact pharma marketing teamsWhat does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers?
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government.
News Pharma Supply Chain People MovesThe latest appointments and promotions across the pharmaceutical supply chain.
News Open letter challenges EU Commission on medicine supply chainIn an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe.
News The Biggest Drug Approvals of 2022A carefully curated list of the most notable drug approvals of the past year, covering neurology, oncology, and COVID-19, as well as a look at the most promising drugs up for review in 2023.
News Eli Lilly gets ready to launch five new drugs in 2023Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets.
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease marketAmgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market.
News Merck to donate new Ebola vaccine to defend against outbreaks in UgandaPharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance